London and Seattle — TB is one of the world’s deadliest diseases, killing about 4,300 people per day, mostly those living in povert Wellcome and the Bill & Melinda Gates Foundation today announced funding to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical trial. If…Read More
Africa Wellcome and the Gates Foundation to Fund LateStage Development of a Tuberculosis Vaccine Candidate That Could Be the First in 100 Years If Proven Effective
